ASIA News
The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.
HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.
It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.
The Korean AI company also plans expansion into Vietnam and Hong Kong.
Trained on local medical laws and treatment guidelines, the model scored 96.4 on the 2025 Korean Medical Licensing Examination.
Also, South Korea's Ministry of Health and Welfare has made more patient data available on the My Health Record app.
Former Zuellig Pharma exec Louis Payet launches Peach Health Asia, aiming to make coach-guided tele-physiotherapy and digital rehabilitation accessible across Southeast Asia.
Also, a Taiwanese consortium is expanding across the Japanese elderly care sector.